Achilles Therapeutics plc

Achilles Therapeutics plcverified

ACHL

Price:

$1.0448

Market Cap:

$42.94M

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therap...[Read more]

Industry

Biotechnology

IPO Date

2021-03-31

Stock Exchange

NASDAQ

Ticker

ACHL

The Enterprise Value as of December 2024 (TTM) for Achilles Therapeutics plc (ACHL) is -39490678.00

According to Achilles Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is -39490678.00. This represents a change of -36.42% compared to the average of -62108657.40 of the last 4 quarters.

Achilles Therapeutics plc (ACHL) Historical Enterprise Value (quarterly & annually)

How has ACHL Enterprise Value performed in the past?

The mean historical Enterprise Value of Achilles Therapeutics plc over the last ten years is 17.89M. The current -39490678.00 Enterprise Value has changed -22171.23% with respect to the historical average. Over the past ten years (40 quarters), ACHL's Enterprise Value was at its highest in in the December 2020 quarter at 510.42M. The Enterprise Value was at its lowest in in the December 2022 quarter at -129194981.00.

Quarterly (TTM)
Annual

Average

17.89M

Median

-80660437.82

Minimum

-129536276.30

Maximum

510.42M

Achilles Therapeutics plc (ACHL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Achilles Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.98%

Maximum Annual Enterprise Value = 510.42M

Minimum Annual Increase = -829.88%

Minimum Annual Enterprise Value = -129536276.30

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-91387949.55-29.45%
2022-129536276.3017.23%
2021-110499652.40-121.65%
2020510.42M-829.88%
2019-69932926.103.98%

Achilles Therapeutics plc (ACHL) Average Enterprise Value

How has ACHL Enterprise Value performed in the past?

The current Enterprise Value of Achilles Therapeutics plc (ACHL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-110474626.08

5-year avg

21.81M

10-year avg

17.89M

Achilles Therapeutics plc (ACHL) Enterprise Value vs. Peers

How is ACHL’s Enterprise Value compared to its peers?

Achilles Therapeutics plc’s Enterprise Value is less than Assembly Biosciences, Inc. (75.96M), less than Spero Therapeutics, Inc. (-8230622.00), less than Instil Bio, Inc. (249.76M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than Nuvation Bio Inc. (923.54M), less than CytomX Therapeutics, Inc. (61.59M), less than NextCure, Inc. (8.79M),

CompanyEnterprise ValueMarket cap
75.96M$102.97M
-8230622.00$63.44M
249.76M$171.08M
-6333315.00$8.20M
923.54M$942.39M
61.59M$91.57M
8.79M$31.10M

Build a custom stock screener for Achilles Therapeutics plc (ACHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achilles Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achilles Therapeutics plc (ACHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achilles Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Achilles Therapeutics plc's Enterprise Value?

What is the highest Enterprise Value for Achilles Therapeutics plc (ACHL)?

What is the 3-year average Enterprise Value for Achilles Therapeutics plc (ACHL)?

What is the 5-year average Enterprise Value for Achilles Therapeutics plc (ACHL)?

How does the current Enterprise Value for Achilles Therapeutics plc (ACHL) compare to its historical average?